354 related articles for article (PubMed ID: 26860519)
1. The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study.
Compagno M; Gullstrand B; Jacobsen S; Eilertsen GØ; Nilsson JÅ; Lood C; Jönsen A; Truedsson L; Sturfelt G; Bengtsson AA
Arthritis Res Ther; 2016 Feb; 18():44. PubMed ID: 26860519
[TBL] [Abstract][Full Text] [Related]
2. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
[TBL] [Abstract][Full Text] [Related]
3. Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.
Compagno M; Jacobsen S; Rekvig OP; Truedsson L; Heegaard NH; Nossent J; Jönsen A; Jacobsen RS; Eilertsen GØ; Sturfelt G; Bengtsson AA
Scand J Rheumatol; 2013; 42(4):311-6. PubMed ID: 23496224
[TBL] [Abstract][Full Text] [Related]
4. Combination of autoantibodies against different histone proteins influences complement-dependent phagocytosis of necrotic cell material by polymorphonuclear leukocytes in systemic lupus erythematosus.
Gullstrand B; Lefort MH; Tydén H; Jönsen A; Lood C; Johansson A; Jacobsen S; Truedsson L; Bengtsson AA
J Rheumatol; 2012 Aug; 39(8):1619-27. PubMed ID: 22753651
[TBL] [Abstract][Full Text] [Related]
5. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
Ren Y; Tang J; Mok MY; Chan AW; Wu A; Lau CS
Arthritis Rheum; 2003 Oct; 48(10):2888-97. PubMed ID: 14558095
[TBL] [Abstract][Full Text] [Related]
6. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
[TBL] [Abstract][Full Text] [Related]
7. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
Kalunian KC; Chatham WW; Massarotti EM; Reyes-Thomas J; Harris C; Furie RA; Chitkara P; Putterman C; Gross RL; Somers EC; Kirou KA; Ramsey-Goldman R; Hsieh C; Buyon JP; Dervieux T; Weinstein A
Arthritis Rheum; 2012 Dec; 64(12):4040-7. PubMed ID: 22932861
[TBL] [Abstract][Full Text] [Related]
8. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus.
Biermann MHC; Boeltz S; Pieterse E; Knopf J; Rech J; Bilyy R; van der Vlag J; Tincani A; Distler JHW; Krönke G; Schett GA; Herrmann M; Muñoz LE
Front Immunol; 2018; 9():989. PubMed ID: 29867966
[TBL] [Abstract][Full Text] [Related]
10. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
Chauhan SK; Rai R; Singh VV; Rai M; Rai G
Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
[TBL] [Abstract][Full Text] [Related]
11. Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.
Yang J; Li Q; Yang X; Li M
Lupus; 2016 Apr; 25(5):513-9. PubMed ID: 26678441
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
[TBL] [Abstract][Full Text] [Related]
13. Beta 2-microglobulin can be a disease activity marker in systemic lupus erythematosus.
Kim HA; Jeon JY; Yoon JM; Suh CH
Am J Med Sci; 2010 Apr; 339(4):337-40. PubMed ID: 20186038
[TBL] [Abstract][Full Text] [Related]
14. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
15. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
[TBL] [Abstract][Full Text] [Related]
17. PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus.
Luo Q; Huang Z; Ye J; Deng Y; Fang L; Li X; Guo Y; Jiang H; Ju B; Huang Q; Li J
Arthritis Res Ther; 2016 Feb; 18():47. PubMed ID: 26867643
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the impairment of the uptake of apoptotic polymorphonuclear cells by monocyte subpopulations in systemic lupus erythematosus.
Mikołajczyk TP; Skiba D; Batko B; Krezelok M; Wilk G; Osmenda G; Pryjma JR; Guzik TJ
Lupus; 2014 Nov; 23(13):1358-69. PubMed ID: 24969081
[TBL] [Abstract][Full Text] [Related]
19. Impaired phagocytosis of apoptotic cell material in serologically active clinically quiescent patients with systemic lupus erythematosis.
Huang WN; Tso TK; Wu HC; Yang HF; Tsay GJ
Int J Rheum Dis; 2016 Dec; 19(12):1310-1316. PubMed ID: 26692544
[TBL] [Abstract][Full Text] [Related]
20. Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity.
Enocsson H; Sjöwall C; Wirestam L; Dahle C; Kastbom A; Rönnelid J; Wetterö J; Skogh T
J Rheumatol; 2015 May; 42(5):817-25. PubMed ID: 25684763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
